Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Southern Asia is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Southern Asia are shifting towards natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are gentle on their digestive system. This preference for natural remedies is driven by the belief that they have fewer side effects and are more sustainable for long-term use. Additionally, there is a growing demand for products that address specific digestive issues such as indigestion, bloating, and acid reflux. Trends in the market include the rise of e-commerce and online pharmacies. With the increasing penetration of smartphones and internet connectivity, consumers are now able to conveniently purchase Digestive & Intestinal Remedies online. This trend is particularly prominent in urban areas where consumers have access to a wider range of products and can compare prices and reviews before making a purchase. Online pharmacies also offer the advantage of discreet purchasing for consumers who may feel uncomfortable discussing digestive issues in person. Local special circumstances in Southern Asia also contribute to the development of the Digestive & Intestinal Remedies market. For example, the region has a diverse cuisine with a wide variety of spices and flavors. While this adds to the culinary experience, it can also lead to digestive discomfort for some individuals. As a result, there is a higher demand for remedies that can alleviate symptoms and provide relief. Additionally, the prevalence of gastrointestinal diseases such as irritable bowel syndrome and gastric ulcers in the region further drives the need for Digestive & Intestinal Remedies. Underlying macroeconomic factors such as increasing disposable income and urbanization also play a role in the growth of the market. As incomes rise, consumers are willing to spend more on healthcare products, including Digestive & Intestinal Remedies. Urbanization leads to lifestyle changes, including a shift towards sedentary jobs and unhealthy eating habits, which can contribute to digestive issues. This, in turn, drives the demand for remedies to address these issues. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Southern Asia is developing due to changing customer preferences, emerging trends such as e-commerce, local special circumstances, and underlying macroeconomic factors. The shift towards natural remedies, the rise of online pharmacies, the diverse cuisine in the region, and the increasing disposable income and urbanization all contribute to the growth of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
